Loading...
Etoposide — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Etoposide
2025-Q4
Comprehensive analysis of India’s etoposide export trade — suppliers, buyers, prices, routes, and every shipment record.
258
Shipments
$1.95M
Trade Value
62
Suppliers
57
Buyers
54
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/etoposide
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s etoposide trade — 2025-Q4
KEY TAKEAWAY
Etoposide 2025-Q4 exports total $2.0M across 54 countries, with INTAS PHARMACEUTICALS LTD commanding 77.4% market share.
TOTAL SHIPMENTS
258
2025-Q4
EXPORT VALUE
$2.0M
FOB USD
TOTAL QUANTITY
313.7K
units shipped
INDIAN SUPPLIERS
62
unique exporters
GLOBAL BUYERS
57
unique importers
DESTINATIONS
54
countries
MEDIAN UNIT PRICE
$4.57
per unit
TOP-5 SHARE
96.4%
of total USD
BRANDED SHARE
36.4%
94 shipments
DOSAGE FORMS
6
product types
6 KEY FINDINGS
1
INTAS PHARMACEUTICALS LTD is India's #1 Etoposide exporter with $1.5M (77.4% market share).→ §5, Indian Supplier Rankings
2
Etoposide reached 54 countries, with Poland as the top destination ($534.8K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 6094) — top 10 suppliers control 98.5% of exports.→ §5, Indian Supplier Rankings
4
96.5% of buyers (55 of 57) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (92.1%) across 6 dosage forms.→ §7, Price Benchmarks
6
54 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 INTAS PHARMACEUTICALS LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian etoposide exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Etoposide report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial etoposide trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian etoposide suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Etoposide India trade report
Product scope
Etoposide
All variants merged — branded and generic formulations of etoposide
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
258
Every commercial etoposide trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $1.2M, Nov $625.1K, Dec $171.5K. Shipment counts were mixed across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.2M
Oct USD
84 shipments
2
$625.1K
Nov USD
-45.8% MoM
3
$171.5K
Dec USD
-72.6% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 45.8% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.2M, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $2.0M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $529K dip in Nov, $454K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1.2M | 84 shipments |
| Nov | $625K | 95 shipments |
| Dec | $171K | 79 shipments |
| Q4 Total | $2.0M | 258 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Netherlands held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: INTAS PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import etoposide from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Poland absorbs 27.4% of India’s 2025-Q4 etoposide trade ($534.8K). Beyond the top 10 destinations, 54 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 16 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 54 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much etoposide India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$32K
1.6% of trade
15 countries · 48 shipments
Europe
$1.7M
86.5% of trade
12 countries · 151 shipments
Americas
$182K
9.3% of trade
10 countries · 19 shipments
Africa
$51K
2.6% of trade
16 countries · 39 shipments
Oceania
$0
0.0% of trade
1 countries · 1 shipments
Fig 4.1 Poland is the #1 corridor ($535K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian etoposide it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Poland | $535K | 29 | INTAS PHARMACEUTICALS LTD | $534K | VAMA LIFECARE PVT LTD | $398 | — | — |
| 2 | Greece | $399K | 36 | INTAS PHARMACEUTICALS LTD | $399K | — | — | — | — |
| 3 | Netherlands | $322K | 31 | INTAS PHARMACEUTICALS LTD | $322K | — | — | — | — |
| 4 | France | $185K | 3 | MYLAN LABORATORIES LTD | $140K | INTAS PHARMACEUTICALS LTD | $44K | — | — |
| 5 | Russia | $96K | 3 | RUS MED EXPORTS PVT LTD | $94K | GENETEC LIFESCIENCES | $2K | UNITED BIOTECH PVT LTD | $700 |
| 6 | United States | $79K | 1 | INTAS PHARMACEUTICALS LTD | $79K | — | — | — | — |
| 7 | Mexico | $75K | 10 | INTAS PHARMACEUTICALS LTD | $72K | MYGENIC HEALTHCARE PVT LTD | $3K | ATLAS ENTERPRISES | $157 |
| 8 | Germany | $68K | 1 | FRESENIUS KABI ONCOLOGY LTD | $68K | — | — | — | — |
| 9 | South Africa | $35K | 3 | FRESENIUS KABI ONCOLOGY LTD | $35K | VENUS REMEDIES LTD | $168 | — | — |
| 10 | United Kingdom | $33K | 2 | INTAS PHARMACEUTICALS LTD | $33K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 1.6% of USD — but Poland is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
27.4%
#1 country share
Poland alone
78.8%
Top 5 share
5 of 54 countries
97.5%
Top 15 share
Long tail of 39 countries = 2.5%
HHI 1610
Destination HHI
Moderately concentrated
54
Countries served
Global pharma reach from India
16
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
62 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
INTAS PHARMACEUTICALS LTD ($1.5M, 77.4% share) and MYLAN LABORATORIES LTD ($140.3K) together control 84.5% of India’s 2025-Q4 etoposide trade. The top 5 suppliers hold 96.4%. 62 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian etoposide suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 INTAS PHARMACEUTICALS LTD leads by $1.4M over MYLAN LABORATORIES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: M.K.PHARMA is #20 by value but #8 by volume.
Fig 5.2 INTAS PHARMACEUTICALS LTD also leads by shipment count (143) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: M.K.PHARMA moves from #8 by volume to #20 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 62 etoposide suppliers split into strategic segments
KEY TAKEAWAY
16 suppliers (25%) generate 99.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 INTAS PHARMACEUTICALS LTD and MYLAN LABORATORIES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.1% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LTD | 3 | 9 | $1.5M |
| 2 | BRUCK PHARMA PVT LTD | 2 | 2 | $3K |
| 3 | J.A. UNITED EXPORTS PVT LTD | 2 | 2 | $2K |
| 4 | MYLAN LABORATORIES LTD | 1 | 1 | $140K |
| 5 | FRESENIUS KABI ONCOLOGY LTD | 1 | 4 | $112K |
| 6 | RUS MED EXPORTS PVT LTD | 1 | 1 | $94K |
| 7 | UNITED BIOTECH PVT LTD | 1 | 4 | $25K |
| 8 | ADMAC LIFESCIENCES | 1 | 1 | $21K |
| 9 | VENUS REMEDIES LTD | 1 | 4 | $11K |
| 10 | KHANDELWAL LABORATORIES PVT LTD | 1 | 1 | $4K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the etoposide manufacturing hubs
KEY TAKEAWAY
Ahmedabad and S.G. Highway together account for $1.5M of India’s 2025-Q4 etoposide trade.
Fig 5.5 Ahmedabad (3 exporters, $1.4M) and S.G. Highway (1 exporters, $140K) are India’s etoposide capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
96.4%
Top 5 share
5 of 62 suppliers
98.5%
Top 10 share
10 of 62 suppliers
99.1%
Top 25% share
16 suppliers = 99% USD
HHI 6094
Supplier HHI
Concentrated
62
Total suppliers
shipped Etoposide in 2025-Q4
20+ cities
Indian hubs
Ahmedabad and S.G. Highway lead
§5.2 Coming next: 3 exporter deep-dive profiles
Each of the top 3 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | INTAS PHARMACEUTICALS LTD | $1.5M |
| #2 | FRESENIUS KABI ONCOLOGY LTD | $112K |
| #3 | UNITED BIOTECH PVT LTD | $25K |
#1
EXPORTER PROFILE #1 OF 3
INTAS PHARMACEUTICALS LTD
Ahmedabad · India’s #1 etoposide supplier by USD · 2025-Q4
2025-Q4 USD
$1.5M
77.4% market share
SHIPMENTS
143
avg $11K/ship
COUNTRIES
9
destination markets
BUYERS
11
9 single-sourced
BRANDED
15%
of shipments
DOSAGE FORMS
3
product types
TOP 9 DESTINATIONS
Poland is the #1 market at $534K (35% of trade), followed by Greece at $399K. 9 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Poland | $534K | 28 | 35.4% |
| 2 | Greece | $399K | 36 | 26.5% |
| 3 | Netherlands | $322K | 31 | 21.3% |
| 4 | United States | $79K | 1 | 5.3% |
| 5 | Mexico | $72K | 2 | 4.8% |
| 6 | France | $44K | 2 | 2.9% |
| 7 | United Kingdom | $33K | 2 | 2.2% |
| 8 | Italy | $16K | 2 | 1.0% |
| 9 | Malta | $10K | 39 | 0.6% |
MONTHLY TREND
Oct peaked at $852K. Dec was the weakest at $120K.
PRODUCT MIX
Injection dominates at 91% of trade. Vaccine (4.8%) and Unknown are secondary formulations.
TOP BUYERS · 9/9 LOCKED IN
9 of 9 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Netherlands | $963K | N/A |
| Undisclosed buyer | Netherlands | $140K | N/A |
| ACCORD HEALTHCARE FRAN… | Netherlands | $84K | ⚠ Locked |
| AMERISOURCE HEALTH SER… | United States | $79K | ⚠ Locked |
| ACCORD FARMA S.A. DE C.V | Mexico | $72K | ⚠ Locked |
| BROCACEF NL:EU HUB | Netherlands | $44K | ⚠ Locked |
| BROCACEF NL : LOCAL | Netherlands | $43K | ⚠ Locked |
| ACCORD HEALTHCARE SING… | Greece | $41K | ⚠ Locked |
| BROCACEF NL : EU HUB | Netherlands | $27K | ⚠ Locked |
| ACCORD HEALTHCARE ITAL… | Italy | $16K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP
INTAS PHARMACEUTICALS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Poland absorbs $534K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 5 importers per destination.
#3
EXPORTER PROFILE #2 OF 3
FRESENIUS KABI ONCOLOGY LTD
New Delhi · India’s #3 etoposide supplier by USD · 2025-Q4
2025-Q4 USD
$112K
5.8% market share
SHIPMENTS
7
avg $16K/ship
COUNTRIES
4
destination markets
BUYERS
5
4 single-sourced
BRANDED
43%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Germany is the #1 market at $68K (60% of trade), followed by South Africa at $35K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Germany | $68K | 1 | 60.3% |
| 2 | South Africa | $35K | 2 | 31.1% |
| 3 | Pakistan | $9K | 2 | 7.7% |
| 4 | Hungary | $1K | 2 | 1.0% |
MONTHLY TREND
Oct peaked at $68K. Dec was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| FRESENIUS KABI DEUTSCH… | Germany | $68K | ⚠ Locked |
| FRESENIUS KABI SOUTH A… | South Africa | $35K | ⚠ Locked |
| Undisclosed buyer | Hungary | $5K | N/A |
| ATCO PHARMA INTERNATIO… | Pakistan | $4K | ⚠ Locked |
| EUROFINS BIOPHARMA PRO… | Hungary | $561 | ⚠ Locked |
#3
EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP
FRESENIUS KABI ONCOLOGY LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P2.3 Germany absorbs $68K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#5
EXPORTER PROFILE #3 OF 3
UNITED BIOTECH PVT LTD
New Delhi · India’s #5 etoposide supplier by USD · 2025-Q4
2025-Q4 USD
$25K
1.3% market share
SHIPMENTS
6
avg $4K/ship
COUNTRIES
4
destination markets
BUYERS
4
2 single-sourced
BRANDED
83%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Lithuania is the #1 market at $21K (82% of trade), followed by Cambodia at $3K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Lithuania | $21K | 1 | 82.3% |
| 2 | Cambodia | $3K | 1 | 12.0% |
| 3 | Nepal | $718 | 3 | 2.9% |
| 4 | Russia | $700 | 1 | 2.8% |
MONTHLY TREND
Nov peaked at $24K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Lithuania | $21K | N/A |
| SAK CAM PHARMA CO LTD | Cambodia | $3K | ⚠ Locked |
| NIKHIL PHARMA PVT LTD | Nepal | $478 | ⚠ Locked |
| Undisclosed buyer | Nepal | $240 | N/A |
#5
EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP
UNITED BIOTECH PVT LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P3.3 Lithuania absorbs $21K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
57 importers across 54 countries — who is buying Indian etoposide and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 40.8% of total USD. 96% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian etoposide. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 CSP P/O VIATRIS SA is the #1 importer at $140K (7.2%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
96%
Single-source
55 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
4%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source etoposide from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Netherlands 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ACCORD HEALTHCARE FRAN… | INTAS PHARMACEUTICAL… | $84K | $12.571 | Injection |
| BROCACEF NL:EU HUB | INTAS PHARMACEUTICAL… | $44K | $9.950 | — |
| BROCACEF NL : LOCAL | INTAS PHARMACEUTICAL… | $43K | $6.975 | Injection |
| BROCACEF NL : EU HUB | INTAS PHARMACEUTICAL… | $27K | $19.550 | — |
Mexico 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ACCORD FARMA S.A. DE C.V | INTAS PHARMACEUTICAL… | $72K | $3.319 | Vaccine |
| DISTRIBUIDORA MEDICA P… | ATLAS ENTERPRISES | $149.828 | $1.498 | — |
| DISTRIBUIDORA MEDICA P… | ATLAS ENTERPRISES | $6.834 | $0.017 | Injection |
Nepal 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SIJAL PHARMA PVT LTD | BETA DRUGS LTD | $1K | $2.711 | Capsule |
| VISION CARE INTERNATIO… | GETWELL PHARMA INDIA… | $1K | $1.102 | Injection |
| NIKHIL PHARMA PVT LTD | UNITED BIOTECH PVT LTD | $477.962 | $1.195 | Injection |
United Arab Emirates 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BEST INTERNATIONAL FZE | MEDEX PHARMACEUTICALS | $848.000 | $1.631 | Injection |
| ZMC EXPRESS CARGO FZCO | SEATRACK INTERNATION… | $614.668 | $3.842 | Capsule |
| MEDIMART DRUG STORE | DROPS PHARMA PVT LTD | $54.847 | $1.371 | Injection |
Russia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| LLC MANAS MED | RUS MED EXPORTS PVT … | $94K | $4.900 | Injection |
| AURORA LLC | GENETEC LIFESCIENCES | $2K | $1.993 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | CSP P/O VIATRIS SA | France | $140K | $140K | Premium |
| 2 | LLC MANAS MED | Russia | $94K | $94K | Premium |
| 3 | ACCORD HEALTHCARE FR… | Netherlands | $84K | $14K | Budget |
| 4 | AMERISOURCE HEALTH S… | United States | $79K | $79K | Premium |
| 5 | ACCORD FARMA S.A. DE… | Mexico | $72K | $36K | Premium |
| 6 | FRESENIUS KABI DEUTS… | Germany | $68K | $68K | Premium |
| 7 | BROCACEF NL:EU HUB | Netherlands | $44K | $11K | Budget |
| 8 | BROCACEF NL : LOCAL | Netherlands | $43K | $21K | Mid |
| 9 | ACCORD HEALTHCARE SI… | Greece | $41K | $2K | Budget |
| 10 | FRESENIUS KABI SOUTH… | South Africa | $35K | $17K | Mid |
| 11 | BROCACEF NL : EU HUB | Netherlands | $27K | $27K | Mid |
| 12 | SPECIALTY LAB SPA | Chile | $21K | $21K | Mid |
| 13 | ACCORD HEALTHCARE IT… | Italy | $16K | $8K | Budget |
| 14 | P D T S A | Costa Rica | $7K | $7K | Budget |
| 15 | MEGA SUNSHINE COMPAN… | Myanmar | $4K | $4K | Budget |
| 16 | ATCO PHARMA INTERNAT… | Pakistan | $4K | $4K | Budget |
| 17 | R M S | Rwanda | $4K | $4K | Budget |
| 18 | SAK CAM PHARMA CO LTD | Cambodia | $3K | $3K | Budget |
| 19 | CENTRALE D ACHATS DE… | Madagascar | $2K | $2K | Budget |
| 20 | AURORA LLC | Russia | $2K | $2K | Budget |
| 21 | TO THE | Rwanda | $2K | $2K | Budget |
| 22 | AL-NOOR FOR DRUGS & … | Yemen | $2K | $398.000 | Budget |
| 23 | SIJAL PHARMA PVT LTD | Nepal | $1K | $1K | Budget |
| 24 | LLC TIBBI JAHON | Tajikistan | $1K | $373.000 | Budget |
| 25 | VISION CARE INTERNAT… | Nepal | $1K | $1K | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 INTAS PHARMACEUTICALS LTD → CSP P/O VIATRIS SA is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian etoposide prices vary by supplier, country and dosage form
KEY TAKEAWAY
Etoposide prices span 1801× ($0.012 → $21.62). The coefficient of variation is 0.89. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.012 | Lowest observed unit price |
| P5 | $0.374 | 5th percentile |
| P25 | $1.44 | 25th percentile (Q1) |
| Median | $4.57 | 50th percentile (Q2) |
| P75 | $8.43 | 75th percentile (Q3) |
| P95 | $18.05 | 95th percentile |
| Max | $21.62 | Highest observed unit price |
| Mean | $5.73 | Arithmetic average |
| CV | 89% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 INTAS PHARMACEUTICALS LTD prices at $8.18/unit vs market median $4.57.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. UNITED BIOTECH PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. INTAS PHARMACEUTICALS LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. NEOPHAR PHARMACEUTICALS PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. RUS MED EXPORTS Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | MYLAN LABORATORI… | France | Injection | 2K | $140K | $75.13 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | United States | Injection | 2K | $79K | $40.91 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 85 | $2K | $21.62 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 391 | $8K | $21.62 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 368 | $8K | $21.36 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 85 | $2K | $21.36 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 913 | $19K | $20.27 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 85 | $2K | $20.27 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 85 | $2K | $20.22 | Sterile formulation premium |
| Oct 2025 | INTAS PHARMACEUT… | Netherlands | Injection | 681 | $14K | $20.22 | Sterile formulation premium |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Capsule | 6K | $40.68 | $0.0066 | |
| Dec 2025 | RMPL PHARMA LLP | Turkey | Injection | 600 | $6.19 | $0.010 | Sterile formulation premium |
| Dec 2025 | M T MADON EXPORTS | Somalia | Injection | 750 | $9.00 | $0.012 | Sterile formulation premium |
| Dec 2025 | VENUS REMEDIES LTD | Colombia | Injection | 8K | $96.71 | $0.012 | Sterile formulation premium |
| Dec 2025 | ATLAS ENTERPRISES | Mexico | Injection | 400 | $6.83 | $0.017 | Sterile formulation premium |
| Dec 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 200 | $4.29 | $0.021 | Sterile formulation premium |
| Dec 2025 | SR FARMALIFE PVT… | Burkina Faso | Injection | 10 | $0.224 | $0.022 | Sterile formulation premium |
| Dec 2025 | RUTVA MEDICARE | Ghana | — | 50 | $1.14 | $0.023 | Small sample / trial shipment |
| Dec 2025 | AL-ROYAL PHARMAC… | Egypt | Capsule | 1K | $44.87 | $0.039 | |
| Dec 2025 | NARAYANA HRUDAYA… | Cayman Islands | Injection | 21 | $0.837 | $0.040 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship etoposide, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Etoposide leaves India through 12+ ports. The top 5 (MUNDRA SEA, AHMEDABAD AIR, BANGALORE AIR) handle 95.1% of total USD. SEA moves 27% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUNDRA SEA handles $1.2M — top 12 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Gdynia is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 27% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.2M
60.0% of USD · 27.1% of ships
AIR
$710K
36.4% of USD · 72.1% of ships
ICD
$71K
3.6% of USD · 0.8% of ships
Fig 8.3 The dominant corridor is MUNDRA SEA → Sea → Europe ($1.2M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Malta is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 2772).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Malta (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 2,772) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| CSP P/O VIATRIS SA | France | MYLAN LABORATORI… | $140K | 1 | HIGH |
| LLC MANAS MED | Russia | RUS MED EXPORTS … | $94K | 1 | MEDIUM |
| ACCORD HEALTHCARE FR… | Netherlands | INTAS PHARMACEUT… | $84K | 6 | MEDIUM |
| AMERISOURCE HEALTH S… | United States | INTAS PHARMACEUT… | $79K | 1 | MEDIUM |
| ACCORD FARMA S.A. DE… | Mexico | INTAS PHARMACEUT… | $72K | 2 | MEDIUM |
| FRESENIUS KABI DEUTS… | Germany | FRESENIUS KABI O… | $68K | 1 | MEDIUM |
| BROCACEF NL:EU HUB | Netherlands | INTAS PHARMACEUT… | $44K | 4 | MEDIUM |
| BROCACEF NL : LOCAL | Netherlands | INTAS PHARMACEUT… | $43K | 2 | MEDIUM |
Conclusion: 55 buyers depend on exactly one Indian supplier, representing $803K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Poland | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Greece | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Russia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Germany | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Lithuania | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Italy | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Malta | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Pakistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in France | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Malta lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Poland (2 suppliers) | This Q | HIGH |
| A6 | Enter Greece (1 suppliers) | This Q | MED |
| A8 | Build Greece distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Poland tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Poland | Other | 2 | $535K | -60.8% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Greece | Other | 1 | $399K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Netherlands | Other | 1 | $322K | -50.5% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | France | Other | 2 | $185K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Russia | Other | 3 | $96K | -97.1% | LOW | Low competition (3 suppliers), accessible market |
| 6 | United States | Other | 1 | $79K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | United Arab Emirates | Other | 4 | $3K | +2876.9% | LOW | Growing 2877% with only 4 competitors |
| 8 | Mexico | Other | 4 | $75K | -95.9% | LOW | Low competition (4 suppliers), accessible market |
| 9 | Germany | Other | 1 | $68K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | South Africa | Africa | 2 | $35K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | United Kingdom | Other | 1 | $33K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Lithuania | Other | 2 | $21K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Chile | Other | 1 | $21K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Italy | Other | 1 | $16K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Malta | Other | 1 | $10K | -95.7% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 258 2025-Q4 Etoposide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/etoposide
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 258 2025-Q4 etoposide shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian etoposide shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
258
across all regions
TOTAL USD
$1.95M
2025-Q4 FOB value
UNITS
313.7K
tablets, capsules, etc.
SUPPLIERS
62
Indian exporters
BUYERS
57
global importers
COUNTRIES
54
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $51K (2.6%), spanning 16 countries.
62 Indian suppliers shipped to 57 buyers across 54 countries — average shipment value $8K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
16 countries · 39 shipments · $51K · 29 Indian suppliers · 17 buyers
SHIPMENTS
39
USD
$51K
COUNTRIES
16
SUPPLIERS
29
BUYERS
17
HHI
4,869
concentrated
Top 16 destination countries in Africa
1
South Africa (69.2%)
$35K
2
Rwanda (11.7%)
$6K
3
Cameroon (4.9%)
$2K
4
Madagascar (3.9%)
$2K
5
Ghana (3.2%)
$2K
6
Kenya (2.4%)
$1K
7
Burundi (1.2%)
$600.00
8
Somalia (0.9%)
$435.86
9
Malawi (0.8%)
$412.13
10
Tanzania (0.5%)
$237.81
11
Uganda (0.4%)
$194.87
12
Seychelles (0.3%)
$165.68
13
Cote d'Ivoire (0.3%)
$153.28
14
Mali (0.3%)
$134.40
15
Egypt (0.1%)
$46.98
16
Burkina Faso (0.0%)
$4.51
Top 29 Indian suppliers into Africa
1
FRESENIUS KABI ONCOLOGY LTD
$35K
2
VENUS REMEDIES LTD
$4K
3
NEOPHAR PHARMACEUTICALS PVT LTD
$2K
4
ZUVIUS LIFESCIENCES PVT LTD
$2K
5
PNT PHARMA
$2K
6
CHAWLA MEDICOS
$2K
7
R.S. SURGIPHARM PVT LTD
$1K
8
BRUCK PHARMA PVT LTD
$600.00
9
RMPL PHARMA LLP
$426.86
10
MATHI ASSOCIATES
$412.13
11
RUN MEDWAY
$254.98
12
BARAKAH BIOHEALTH LLP
$237.81
13
SUBHRA PHARMA PRIAVATE LTD
$222.53
14
SAYAR LIFE-CARE
$165.68
15
KLV HEALTHCARE PVT LTD
$163.28
16
KHATU ENTERPRISES
$134.40
17
SAMEEKSHA PHARMACEUTICALS PVT LTD
$107.91
18
SOINS IMPEX
$103.30
19
ZYPHARS PHARMACEUTICS PVT LTD
$91.57
20
DM WORLDWIDE TRADING
$45.38
21
AL-ROYAL PHARMACEUTICAL PVT LTD
$44.87
22
MELON GLOBALCARE
$29.02
23
VAMA HEALTH WORLD LLP
$27.59
24
M T MADON EXPORTS
$9.00
25
SANSKRUTI PHARMA
$4.29
26
J.A. UNITED EXPORTS PVT LTD
$2.12
27
RUTVA MEDICARE
$1.14
28
GETWELL PHARMA INDIA PVT LTD
$0.865
29
SR FARMALIFE PVT LTD
$0.224
Top 15 Africa importers
1
FRESENIUS KABI SOUTH AFRICA (PTY) L · South Africa
$35K
2
R M S · Rwanda
$4K
3
CENTRALE D ACHATS DE MEDICAMENTS · Madagascar
$2K
4
TO THE · Rwanda
$2K
5
PHARMACHEIME LTD · Malawi
$412.13
6
CLYZ PHARMA SARL · Cameroon
$254.98
7
R P L · South Africa
$167.89
8
MINISTRY OF HEALTH ( CLAUDE JULIEN · Seychelles
$165.68
9
OUMAR KONE · Mali
$134.40
10
PH.EBENA · Cote d'Ivoire
$107.91
11
ROYAL PHARMA COMPANY · Egypt
$44.87
12
AS PER INVOICE GHANA · Ghana
$27.59
13
MOHAMED AHEMED MOHAMUD · Somalia
$9.00
14
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Egypt
$2.12
15
HANITRA RAZAOARIMANANA · Madagascar
$0.865
Top 5 dosage forms
1
Injection
$48K
2
Tablet
$2K
3
Capsule
$466.26
4
Vial
$328.96
5
Unknown
$1.14
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $237.81 | $237.81 |
| Nov | 8 | $37K | $5K |
| Dec | 30 | $13K | $448.76 |
Shipment register · 39 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — FRESENIUS KABI ONCOLOGY LTD · 2 shipments · $35K | |||||||||||
| 1 | Nov 2025 | FRESENIUS KABI SOUTH AFRICA (PTY) L | South Africa | Injection | 4.7K | NOS | $3.73 | $17K | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| 2 | Nov 2025 | FRESENIUS KABI SOUTH AFRICA (PTY) L | South Africa | Injection | 4.7K | NOS | $3.73 | $17K | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| SUPPLIER #2 — VENUS REMEDIES LTD · 2 shipments · $4K | |||||||||||
| 3 | Dec 2025 | R P L | South Africa | Injection | 50 | NOS | $3.36 | $167.89 | DELHI AIR | JOHANNESBURG - JOHAN | AIR |
| 4 | Dec 2025 | R M S | Rwanda | Injection | 2.1K | VLS | $1.92 | $4K | DELHI AIR | KIGALI - | AIR |
| SUPPLIER #3 — NEOPHAR PHARMACEUTICALS PVT LTD · 1 shipments · $2K | |||||||||||
| 5 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 1.0K | VLS | $2.02 | $2K | DELHI AIR | DOUALA | AIR |
| SUPPLIER #4 — ZUVIUS LIFESCIENCES PVT LTD · 1 shipments · $2K | |||||||||||
| 6 | Dec 2025 | CENTRALE D ACHATS DE MEDICAMENTS | Madagascar | Injection | 750 | VLS | $2.66 | $2K | MUMBAI AIR (SAHAR) | ANTANANARIVO | AIR |
| SUPPLIER #5 — PNT PHARMA · 1 shipments · $2K | |||||||||||
| 7 | Dec 2025 | TO THE | Rwanda | Tablet | 2.0K | VLS | $0.959 | $2K | MUMBAI AIR (SAHAR) | KIGALI - | AIR |
| SUPPLIER #6 — CHAWLA MEDICOS · 1 shipments · $2K | |||||||||||
| 8 | Nov 2025 | UNLISTED BUYER | Ghana | Injection | 200 | PCS | $7.92 | $2K | DELHI AIR | ACCRA | AIR |
| SUPPLIER #7 — R.S. SURGIPHARM PVT LTD · 5 shipments · $1K | |||||||||||
| 9 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 90 | VLS | $1.22 | $109.94 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 10 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 10 | VLS | $1.22 | $12.22 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 11 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 150 | VLS | $1.22 | $183.24 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 12 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 300 | VLS | $1.38 | $413.34 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 13 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 200 | VLS | $1.42 | $283.53 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #8 — BRUCK PHARMA PVT LTD · 1 shipments · $600.00 | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Burundi | Injection | 300 | NOS | $2.00 | $600.00 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #9 — RMPL PHARMA LLP · 1 shipments · $426.86 | |||||||||||
| 15 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 500 | NOS | $0.854 | $426.86 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #10 — MATHI ASSOCIATES · 3 shipments · $412.13 | |||||||||||
| 16 | Nov 2025 | PHARMACHEIME LTD | Malawi | Injection | 100 | VLS | $1.62 | $162.03 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| 17 | Nov 2025 | PHARMACHEIME LTD | Malawi | Injection | 100 | VLS | $1.62 | $162.03 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| 18 | Nov 2025 | PHARMACHEIME LTD | Malawi | Tablet | 19 | VLS | $4.64 | $88.08 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #11 — RUN MEDWAY · 1 shipments · $254.98 | |||||||||||
| 19 | Dec 2025 | CLYZ PHARMA SARL | Cameroon | Injection | 200 | NOS | $1.27 | $254.98 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #12 — BARAKAH BIOHEALTH LLP · 1 shipments · $237.81 | |||||||||||
| 20 | Oct 2025 | UNLISTED BUYER | Tanzania | Injection | 150 | NOS | $1.59 | $237.81 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #13 — SUBHRA PHARMA PRIAVATE LTD · 2 shipments · $222.53 | |||||||||||
| 21 | Dec 2025 | UNLISTED BUYER | Kenya | Capsule | 50 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 22 | Dec 2025 | UNLISTED BUYER | Kenya | Capsule | 50 | NOS | $4.45 | $222.53 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #14 — SAYAR LIFE-CARE · 1 shipments · $165.68 | |||||||||||
| 23 | Dec 2025 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | Vial | 24 | NOS | $6.90 | $165.68 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #15 — KLV HEALTHCARE PVT LTD · 1 shipments · $163.28 | |||||||||||
| 24 | Dec 2025 | UNLISTED BUYER | Cameroon | Vial | 100 | NOS | $1.63 | $163.28 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #16 — KHATU ENTERPRISES · 1 shipments · $134.40 | |||||||||||
| 25 | Dec 2025 | OUMAR KONE | Mali | Injection | 100 | NOS | $1.34 | $134.40 | MUMBAI AIR (SAHAR) | BAMAKO | AIR |
| SUPPLIER #17 — SAMEEKSHA PHARMACEUTICALS PVT LTD · 1 shipments · $107.91 | |||||||||||
| 26 | Dec 2025 | PH.EBENA | Cote d'Ivoire | Injection | 50 | NOS | $2.16 | $107.91 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
| SUPPLIER #18 — SOINS IMPEX · 1 shipments · $103.30 | |||||||||||
| 27 | Nov 2025 | UNLISTED BUYER | Uganda | Capsule | 20 | NOS | $5.16 | $103.30 | AHMEDABAD AIR | KAMPALA | AIR |
| SUPPLIER #19 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $91.57 | |||||||||||
| 28 | Dec 2025 | UNKNOWN BUYER | Uganda | Capsule | 15 | NOS | $6.10 | $91.57 | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| SUPPLIER #20 — DM WORLDWIDE TRADING · 1 shipments · $45.38 | |||||||||||
| 29 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Injection | 10 | NOS | $4.54 | $45.38 | AHMEDABAD AIR | ABIDJAN | AIR |
| SUPPLIER #21 — AL-ROYAL PHARMACEUTICAL PVT LTD · 1 shipments · $44.87 | |||||||||||
| 30 | Dec 2025 | ROYAL PHARMA COMPANY | Egypt | Capsule | 1.1K | NOS | $0.039 | $44.87 | DELHI AIR | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #22 — MELON GLOBALCARE · 1 shipments · $29.02 | |||||||||||
| 31 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 30 | NOS | $0.967 | $29.02 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #23 — VAMA HEALTH WORLD LLP · 2 shipments · $27.59 | |||||||||||
| 32 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Injection | 16 | NOS | $1.61 | $25.71 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 33 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Capsule | 30 | NOS | $0.063 | $1.88 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #24 — M T MADON EXPORTS · 1 shipments · $9.00 | |||||||||||
| 34 | Dec 2025 | MOHAMED AHEMED MOHAMUD | Somalia | Injection | 750 | NOS | $0.012 | $9.00 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #25 — SANSKRUTI PHARMA · 1 shipments · $4.29 | |||||||||||
| 35 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 200 | VLS | $0.021 | $4.29 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #26 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $2.12 | |||||||||||
| 36 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Capsule | 40 | NOS | $0.053 | $2.12 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| SUPPLIER #27 — RUTVA MEDICARE · 1 shipments · $1.14 | |||||||||||
| 37 | Dec 2025 | UNLISTED BUYER | Ghana | 50 | NOS | $0.023 | $1.14 | MUMBAI AIR (SAHAR) | ACCRA | AIR | |
| SUPPLIER #28 — GETWELL PHARMA INDIA PVT LTD · 1 shipments · $0.865 | |||||||||||
| 38 | Nov 2025 | HANITRA RAZAOARIMANANA | Madagascar | Injection | 4 | NOS | $0.216 | $0.865 | DELHI AIR | ANTANANARIVO | AIR |
| SUPPLIER #29 — SR FARMALIFE PVT LTD · 1 shipments · $0.224 | |||||||||||
| 39 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 10 | NOS | $0.022 | $0.224 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
15 countries · 48 shipments · $32K · 23 Indian suppliers · 19 buyers
SHIPMENTS
48
USD
$32K
COUNTRIES
15
SUPPLIERS
23
BUYERS
19
HHI
1,252
competitive
Top 15 destination countries in Asia
1
Pakistan (27.3%)
$9K
2
Myanmar (20.8%)
$7K
3
Cambodia (12.7%)
$4K
4
Nepal (10.1%)
$3K
5
United Arab Emirates (8.2%)
$3K
6
Tajikistan (5.6%)
$2K
7
Yemen (5.0%)
$2K
8
Iraq (4.5%)
$1K
9
Sri Lanka (1.5%)
$481.09
10
China (1.5%)
$465.43
11
Lebanon (1.1%)
$331.61
12
Malaysia (0.9%)
$279.50
13
Singapore (0.6%)
$184.98
14
Maldives (0.2%)
$70.29
15
Turkey (0.0%)
$6.19
Top 23 Indian suppliers into Asia
1
FRESENIUS KABI ONCOLOGY LTD
$9K
2
KHANDELWAL LABORATORIES PVT LTD
$4K
3
UNITED BIOTECH PVT LTD
$4K
4
BIOZENTA LIFESCIENCE PVT LTD
$2K
5
J.A. UNITED EXPORTS PVT LTD
$2K
6
GETWELL PHARMA INDIA PVT LTD
$2K
7
BETA DRUGS LTD
$1K
8
M.K.PHARMA
$1K
9
VANDAN HEALTHCARE
$1K
10
MEDEX PHARMACEUTICALS
$848.00
11
ZIL PHARMA
$817.59
12
VATS INDUSTRIES PVT LTD
$773.61
13
ZEAL PHARMA
$656.59
14
GALAXY SUPER SPECIALITY
$636.82
15
SEATRACK INTERNATIONAL TRADEX PVT LTD
$614.67
16
JMB PHARMACEUTICALS PVT LTD
$465.43
17
TRIKAYA GLOBAL
$331.61
18
DROPS PHARMA PVT LTD
$312.22
19
MUNANI PHARMACEUTICALS PVT LTD
$278.36
20
PHARMA CHOICE LLP
$184.98
21
MC PHARMA DISTRIBUTORS
$70.29
22
RMPL PHARMA LLP
$6.19
23
ZYPHARS PHARMACEUTICS PVT LTD
$1.14
Top 17 Asia importers
1
MEGA SUNSHINE COMPANY LTD · Myanmar
$4K
2
ATCO PHARMA INTERNATIONAL PVT LTD · Pakistan
$4K
3
SAK CAM PHARMA CO LTD · Cambodia
$3K
4
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$2K
5
SIJAL PHARMA PVT LTD · Nepal
$1K
6
LLC TIBBI JAHON · Tajikistan
$1K
7
VISION CARE INTERNATIONAL PVT LTD · Nepal
$1K
8
BEST INTERNATIONAL FZE · United Arab Emirates
$848.00
9
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$614.67
10
THE ESSES PHARMACY (PRIVATE) · Sri Lanka
$481.09
11
NIKHIL PHARMA PVT LTD · Nepal
$477.96
12
DALIAN CHAOHONGSUPPLY CHAIN MANAGEM · China
$465.43
13
ATLAS TRADING COMPANY · Iraq
$386.80
14
RADEEP SERVICES · Singapore
$184.98
15
AUTOMOBILE TRANSPORTATION SERVICES · Lebanon
$165.80
16
STATE TRADING ORGANIZATION PLC · Maldives
$70.29
17
MEDIMART DRUG STORE · United Arab Emirates
$54.85
Top 5 dosage forms
1
Injection
$21K
2
Capsule
$9K
3
Vial
$1K
4
Tablet
$386.81
5
Unknown
$386.80
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $520.28 | $260.14 |
| Nov | 22 | $22K | $1K |
| Dec | 24 | $9K | $365.34 |
Shipment register · 48 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — FRESENIUS KABI ONCOLOGY LTD · 2 shipments · $9K | |||||||||||
| 1 | Nov 2025 | ATCO PHARMA INTERNATIONAL PVT LTD | Pakistan | Injection | 3.0K | NOS | $1.44 | $4K | DELHI AIR | KARACHI - | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Pakistan | Injection | 3.0K | NOS | $1.44 | $4K | DELHI AIR | KARACHI - | AIR |
| SUPPLIER #2 — KHANDELWAL LABORATORIES PVT LTD · 1 shipments · $4K | |||||||||||
| 3 | Nov 2025 | MEGA SUNSHINE COMPANY LTD | Myanmar | Capsule | 1.1K | NOS | $3.83 | $4K | MUMBAI AIR (SAHAR) | YANGON | AIR |
| SUPPLIER #3 — UNITED BIOTECH PVT LTD · 4 shipments · $4K | |||||||||||
| 4 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 200 | PCS | $1.20 | $239.56 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Nepal | Injection | 200 | PCS | $1.20 | $239.56 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 6 | Nov 2025 | SAK CAM PHARMA CO LTD | Cambodia | Injection | 2.0K | VLS | $1.50 | $3K | TUGHLAKABAD ICD | Sihanoukville (Kompo | ICD |
| 7 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 200 | PCS | $1.19 | $238.41 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #4 — BIOZENTA LIFESCIENCE PVT LTD · 2 shipments · $2K | |||||||||||
| 8 | Dec 2025 | UNLISTED BUYER | Myanmar | Injection | 1.0K | VLS | $1.23 | $1K | DELHI AIR | YANGON | AIR |
| 9 | Dec 2025 | UNLISTED BUYER | Myanmar | Injection | 100 | VLS | $9.96 | $996.01 | DELHI AIR | YANGON | AIR |
| SUPPLIER #5 — J.A. UNITED EXPORTS PVT LTD · 3 shipments · $2K | |||||||||||
| 10 | Nov 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Capsule | 300 | NOS | $4.79 | $1K | MUMBAI AIR (SAHAR) | ADEN | AIR |
| 11 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 50 | NOS | $1.22 | $61.20 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| 12 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Capsule | 20 | NOS | $4.57 | $91.39 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #6 — GETWELL PHARMA INDIA PVT LTD · 2 shipments · $2K | |||||||||||
| 13 | Dec 2025 | VISION CARE INTERNATIONAL PVT LTD | Nepal | Injection | 1.0K | NOS | $1.10 | $1K | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 14 | Dec 2025 | THE ESSES PHARMACY (PRIVATE) | Sri Lanka | Injection | 250 | NOS | $1.92 | $481.09 | DELHI AIR | COLOMBO | AIR |
| SUPPLIER #7 — BETA DRUGS LTD · 1 shipments · $1K | |||||||||||
| 15 | Dec 2025 | SIJAL PHARMA PVT LTD | Nepal | Capsule | 500 | NOS | $2.71 | $1K | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #8 — M.K.PHARMA · 3 shipments · $1K | |||||||||||
| 16 | Nov 2025 | LLC TIBBI JAHON | Tajikistan | Vial | 160 | PCS | $1.12 | $179.00 | DELHI AIR | DUSHANBE | AIR |
| 17 | Nov 2025 | LLC TIBBI JAHON | Tajikistan | Vial | 420 | PCS | $1.12 | $469.86 | DELHI AIR | DUSHANBE | AIR |
| 18 | Nov 2025 | LLC TIBBI JAHON | Tajikistan | Vial | 420 | PCS | $1.12 | $469.86 | DELHI AIR | DUSHANBE | AIR |
| SUPPLIER #9 — VANDAN HEALTHCARE · 1 shipments · $1K | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Cambodia | Injection | 150 | NOS | $6.74 | $1K | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #10 — MEDEX PHARMACEUTICALS · 4 shipments · $848.00 | |||||||||||
| 20 | Nov 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 20 | NOS | $1.60 | $31.96 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 21 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 100 | NOS | $1.63 | $163.28 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 22 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 200 | NOS | $1.63 | $326.38 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 23 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 200 | NOS | $1.63 | $326.38 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #11 — ZIL PHARMA · 1 shipments · $817.59 | |||||||||||
| 24 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 450 | NOS | $1.82 | $817.59 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #12 — VATS INDUSTRIES PVT LTD · 2 shipments · $773.61 | |||||||||||
| 25 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | 100 | NOS | $3.87 | $386.80 | DELHI AIR | BAGDAD, METROPOLITAN | AIR | |
| 26 | Nov 2025 | UNKNOWN BUYER | Iraq | Tablet | 100 | NOS | $3.87 | $386.81 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #13 — ZEAL PHARMA · 5 shipments · $656.59 | |||||||||||
| 27 | Nov 2025 | UNLISTED BUYER | Iraq | Capsule | 30 | NOS | $3.81 | $114.39 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| 28 | Nov 2025 | UNLISTED BUYER | Iraq | Capsule | 50 | NOS | $4.38 | $218.95 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| 29 | Nov 2025 | UNLISTED BUYER | Iraq | Capsule | 30 | NOS | $3.81 | $114.39 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| 30 | Dec 2025 | UNLISTED BUYER | Iraq | Capsule | 25 | NOS | $4.18 | $104.42 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| 31 | Dec 2025 | UNLISTED BUYER | Iraq | Capsule | 25 | NOS | $4.18 | $104.42 | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #14 — GALAXY SUPER SPECIALITY · 1 shipments · $636.82 | |||||||||||
| 32 | Nov 2025 | UNLISTED BUYER | Tajikistan | Injection | 500 | NOS | $1.27 | $636.82 | DELHI AIR | TASHKENT | AIR |
| SUPPLIER #15 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 3 shipments · $614.67 | |||||||||||
| 33 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Capsule | 100 | NOS | $4.46 | $445.74 | DELHI AIR | DUBAI | AIR |
| 34 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Capsule | 30 | NOS | $4.46 | $133.87 | DELHI AIR | DUBAI | AIR |
| 35 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Injection | 30 | NOS | $1.17 | $35.06 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #16 — JMB PHARMACEUTICALS PVT LTD · 3 shipments · $465.43 | |||||||||||
| 36 | Oct 2025 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | Injection | 300 | NOS | $1.55 | $465.43 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 37 | Dec 2025 | UNLISTED BUYER | China | Injection | 300 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 38 | Dec 2025 | UNLISTED BUYER | China | Injection | 300 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| SUPPLIER #17 — TRIKAYA GLOBAL · 2 shipments · $331.61 | |||||||||||
| 39 | Nov 2025 | AUTOMOBILE TRANSPORTATION SERVICES | Lebanon | Capsule | 30 | PCS | $5.53 | $165.80 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 40 | Nov 2025 | UNKNOWN BUYER | Lebanon | Capsule | 30 | PCS | $5.53 | $165.80 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #18 — DROPS PHARMA PVT LTD · 3 shipments · $312.22 | |||||||||||
| 41 | Oct 2025 | MEDIMART DRUG STORE | United Arab Emirates | Injection | 40 | NOS | $1.37 | $54.85 | COCHIN SEA | DUBAI | AIR |
| 42 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 40 | NOS | $1.38 | $55.34 | COCHIN AIR | DUBAI | AIR |
| 43 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 100 | NOS | $2.02 | $202.04 | COCHIN AIR | DUBAI | AIR |
| SUPPLIER #19 — MUNANI PHARMACEUTICALS PVT LTD · 1 shipments · $278.36 | |||||||||||
| 44 | Dec 2025 | UNKNOWN BUYER | Malaysia | Capsule | 52 | NOS | $5.35 | $278.36 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #20 — PHARMA CHOICE LLP · 1 shipments · $184.98 | |||||||||||
| 45 | Nov 2025 | RADEEP SERVICES | Singapore | Injection | 150 | NOS | $1.23 | $184.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #21 — MC PHARMA DISTRIBUTORS · 1 shipments · $70.29 | |||||||||||
| 46 | Dec 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Capsule | 128 | PCS | $0.549 | $70.29 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #22 — RMPL PHARMA LLP · 1 shipments · $6.19 | |||||||||||
| 47 | Dec 2025 | UNLISTED BUYER | Turkey | Injection | 600 | NOS | $0.010 | $6.19 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #23 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $1.14 | |||||||||||
| 48 | Dec 2025 | UNKNOWN BUYER | Malaysia | Capsule | 20 | NOS | $0.057 | $1.14 | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
12 countries · 151 shipments · $1.69M · 9 Indian suppliers · 15 buyers
SHIPMENTS
151
USD
$1.69M
COUNTRIES
12
SUPPLIERS
9
BUYERS
15
HHI
6,600
concentrated
Top 12 destination countries in Europe
1
Poland (31.7%)
$535K
2
Greece (23.7%)
$399K
3
Netherlands (19.1%)
$322K
4
France (10.9%)
$185K
5
Russia (5.7%)
$96K
6
Germany (4.0%)
$68K
7
United Kingdom (1.9%)
$33K
8
Lithuania (1.2%)
$21K
9
Italy (0.9%)
$16K
10
Malta (0.6%)
$10K
11
Bosnia and Herzegovina (0.1%)
$2K
12
Hungary (0.1%)
$1K
Top 9 Indian suppliers into Europe
1
INTAS PHARMACEUTICALS LTD
$1.36M
2
MYLAN LABORATORIES LTD
$140K
3
RUS MED EXPORTS PVT LTD
$94K
4
FRESENIUS KABI ONCOLOGY LTD
$69K
5
UNITED BIOTECH PVT LTD
$21K
6
BRUCK PHARMA PVT LTD
$2K
7
GENETEC LIFESCIENCES
$2K
8
VAMA LIFECARE PVT LTD
$397.75
9
SPECIALITY MEDICINES LTD
$28.00
Top 13 Europe importers
1
CSP P/O VIATRIS SA · France
$140K
2
LLC MANAS MED · Russia
$94K
3
ACCORD HEALTHCARE FRANCE SAS · Netherlands
$84K
4
FRESENIUS KABI DEUTSCHLAND GMBH · Germany
$68K
5
BROCACEF NL:EU HUB · Netherlands
$44K
6
BROCACEF NL : LOCAL · Netherlands
$43K
7
ACCORD HEALTHCARE SINGLE MEMBER SA · Greece
$41K
8
BROCACEF NL : EU HUB · Netherlands
$27K
9
ACCORD HEALTHCARE ITALIA SRL · Italy
$16K
10
AURORA LLC · Russia
$2K
11
EUROFINS BIOPHARMA PRODUCT TESTING · Hungary
$561.48
12
AS PER INVOICE POLAND · Poland
$397.75
13
ACCORD HEALTHCARE SM SA · Greece
$157.99
Top 4 dosage forms
1
Injection
$1.62M
2
Unknown
$33K
3
Solution
$33K
4
Capsule
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 78 | $1.00M | $13K |
| Nov | 60 | $559K | $9K |
| Dec | 13 | $126K | $10K |
Shipment register · 151 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INTAS PHARMACEUTICALS LTD · 140 shipments · $1.36M | |||||||||||
| 1 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 391 | VLS | $21.62 | $8K | MUNDRA SEA | ROTTERDAM | SEA |
| 2 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 85 | VLS | $21.62 | $2K | MUNDRA SEA | ROTTERDAM | SEA |
| 3 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 808 | VLS | $7.85 | $6K | MUNDRA SEA | ROTTERDAM | SEA |
| 4 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 77 | VLS | $6.18 | $475.81 | MUNDRA SEA | ROTTERDAM | SEA |
| 5 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 1.8K | VLS | $7.06 | $13K | MUNDRA SEA | ROTTERDAM | SEA |
| 6 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 115 | VLS | $7.06 | $811.67 | MUNDRA SEA | ROTTERDAM | SEA |
| 7 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 368 | VLS | $21.36 | $8K | MUNDRA SEA | ROTTERDAM | SEA |
| 8 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 85 | VLS | $21.36 | $2K | MUNDRA SEA | ROTTERDAM | SEA |
| 9 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $6.36 | $228.88 | AHMEDABAD AIR | MALTA | AIR |
| 10 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $6.25 | $224.86 | AHMEDABAD AIR | MALTA | AIR |
| 11 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 21 | VLS | $17.04 | $357.85 | AHMEDABAD AIR | MALTA | AIR |
| 12 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $10.21 | $265.40 | AHMEDABAD AIR | MALTA | AIR |
| 13 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $9.21 | $239.45 | AHMEDABAD AIR | MALTA | AIR |
| 14 | Oct 2025 | ACCORD HEALTHCARE ITALIA SRL | Italy | Injection | 878 | VLS | $16.12 | $14K | AHMEDABAD AIR | MILAN - MALPENSA | AIR |
| 15 | Oct 2025 | ACCORD HEALTHCARE ITALIA SRL | Italy | Injection | 85 | VLS | $16.12 | $1K | AHMEDABAD AIR | MILAN - MALPENSA | AIR |
| 16 | Oct 2025 | ACCORD HEALTHCARE SM SA | Greece | Injection | 100 | NOS | $0.527 | $52.66 | AHMEDABAD AIR | ATHENS | AIR |
| 17 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 3.0K | VLS | $7.17 | $21K | MUNDRA SEA | GDYNIA | SEA |
| 18 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 115 | VLS | $7.17 | $825.05 | MUNDRA SEA | GDYNIA | SEA |
| 19 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 3.6K | VLS | $9.69 | $35K | AHMEDABAD AIR | WARSAW | AIR |
| 20 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 115 | VLS | $9.69 | $1K | AHMEDABAD AIR | WARSAW | AIR |
| 21 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $9.83 | $255.46 | AHMEDABAD AIR | MALTA | AIR |
| 22 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $7.98 | $287.28 | AHMEDABAD AIR | MALTA | AIR |
| 23 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $7.98 | $287.28 | AHMEDABAD AIR | MALTA | AIR |
| 24 | Oct 2025 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | Injection | 2.8K | VLS | $11.55 | $33K | MUNDRA SEA | ROTTERDAM | SEA |
| 25 | Oct 2025 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | Injection | 95 | VLS | $11.55 | $1K | MUNDRA SEA | ROTTERDAM | SEA |
| 26 | Oct 2025 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | Injection | 2.9K | VLS | $11.61 | $33K | MUNDRA SEA | ROTTERDAM | SEA |
| 27 | Oct 2025 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | Injection | 95 | VLS | $11.61 | $1K | MUNDRA SEA | ROTTERDAM | SEA |
| 28 | Oct 2025 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | Injection | 681 | VLS | $20.22 | $14K | MUNDRA SEA | ROTTERDAM | SEA |
| 29 | Oct 2025 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | Injection | 85 | VLS | $20.22 | $2K | MUNDRA SEA | ROTTERDAM | SEA |
| 30 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 913 | VLS | $20.27 | $19K | MUNDRA SEA | ROTTERDAM | SEA |
| 31 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 85 | VLS | $20.27 | $2K | MUNDRA SEA | ROTTERDAM | SEA |
| 32 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 2.0K | VLS | $11.37 | $22K | MUNDRA SEA | ROTTERDAM | SEA |
| 33 | Oct 2025 | UNLISTED BUYER | Netherlands | Injection | 95 | VLS | $11.37 | $1K | MUNDRA SEA | ROTTERDAM | SEA |
| 34 | Oct 2025 | ACCORD HEALTHCARE SM SA | Greece | Injection | 100 | NOS | $0.527 | $52.66 | AHMEDABAD AIR | ATHENS | AIR |
| 35 | Oct 2025 | ACCORD HEALTHCARE SM SA | Greece | Injection | 100 | NOS | $0.527 | $52.66 | AHMEDABAD AIR | ATHENS | AIR |
| 36 | Oct 2025 | UNLISTED BUYER | United Kingdom | Solution | 2.9K | VLS | $11.05 | $32K | MUNDRA SEA | Felixstowe | SEA |
| 37 | Oct 2025 | UNLISTED BUYER | United Kingdom | Solution | 95 | VLS | $11.05 | $1K | MUNDRA SEA | Felixstowe | SEA |
| 38 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.877 | $21.94 | AHMEDABAD AIR | ATHENS | AIR |
| 39 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.877 | $21.94 | AHMEDABAD AIR | ATHENS | AIR |
| 40 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.877 | $21.94 | AHMEDABAD AIR | ATHENS | AIR |
| 41 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.877 | $21.94 | AHMEDABAD AIR | ATHENS | AIR |
| 42 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.877 | $21.94 | AHMEDABAD AIR | ATHENS | AIR |
| 43 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.877 | $21.94 | AHMEDABAD AIR | ATHENS | AIR |
| 44 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.877 | $21.94 | AHMEDABAD AIR | ATHENS | AIR |
| 45 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.877 | $21.94 | AHMEDABAD AIR | ATHENS | AIR |
| 46 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $9.95 | $258.63 | AHMEDABAD AIR | MALTA | AIR |
| 47 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $9.86 | $256.47 | AHMEDABAD AIR | MALTA | AIR |
| 48 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 21 | VLS | $17.39 | $365.19 | AHMEDABAD AIR | MALTA | AIR |
| 49 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 38 | VLS | $4.74 | $180.23 | AHMEDABAD AIR | MALTA | AIR |
| 50 | Oct 2025 | UNLISTED BUYER | France | Injection | 7.1K | VLS | $6.11 | $44K | AHMEDABAD AIR | PARIS - CHARLES DE G | AIR |
| 51 | Oct 2025 | UNLISTED BUYER | France | Injection | 119 | VLS | $6.11 | $726.65 | AHMEDABAD AIR | PARIS - CHARLES DE G | AIR |
| 52 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 799 | VLS | $10.74 | $9K | MUNDRA SEA | Piraeus | SEA |
| 53 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 95 | VLS | $10.74 | $1K | MUNDRA SEA | Piraeus | SEA |
| 54 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 17.1K | VLS | $6.13 | $105K | MUNDRA SEA | Piraeus | SEA |
| 55 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 17.1K | VLS | $6.13 | $105K | MUNDRA SEA | Piraeus | SEA |
| 56 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 118 | VLS | $6.13 | $723.91 | MUNDRA SEA | Piraeus | SEA |
| 57 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 118 | VLS | $6.13 | $723.91 | MUNDRA SEA | Piraeus | SEA |
| 58 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 3.1K | VLS | $18.22 | $57K | MUNDRA SEA | Piraeus | SEA |
| 59 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 3.3K | VLS | $18.22 | $59K | MUNDRA SEA | Piraeus | SEA |
| 60 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 84 | VLS | $18.22 | $2K | MUNDRA SEA | Piraeus | SEA |
| 61 | Oct 2025 | UNLISTED BUYER | Greece | Injection | 84 | VLS | $18.22 | $2K | MUNDRA SEA | Piraeus | SEA |
| 62 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 38 | VLS | $4.94 | $187.63 | AHMEDABAD AIR | MALTA | AIR |
| 63 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 38 | VLS | $4.94 | $187.63 | AHMEDABAD AIR | MALTA | AIR |
| 64 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 21 | VLS | $14.68 | $308.33 | AHMEDABAD AIR | MALTA | AIR |
| 65 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 21 | VLS | $14.68 | $308.33 | AHMEDABAD AIR | MALTA | AIR |
| 66 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $8.92 | $231.82 | AHMEDABAD AIR | MALTA | AIR |
| 67 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 38 | VLS | $4.63 | $176.00 | AHMEDABAD AIR | MALTA | AIR |
| 68 | Oct 2025 | UNLISTED BUYER | Malta | Injection | 38 | VLS | $4.63 | $176.00 | AHMEDABAD AIR | MALTA | AIR |
| 69 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.871 | $21.78 | AHMEDABAD AIR | ATHENS | AIR |
| 70 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.871 | $21.78 | AHMEDABAD AIR | ATHENS | AIR |
| 71 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.871 | $21.78 | AHMEDABAD AIR | ATHENS | AIR |
| 72 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.871 | $21.78 | AHMEDABAD AIR | ATHENS | AIR |
| 73 | Oct 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.871 | $21.78 | AHMEDABAD AIR | ATHENS | AIR |
| 74 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 3.6K | VLS | $9.64 | $35K | AHMEDABAD AIR | WARSAW | AIR |
| 75 | Oct 2025 | UNLISTED BUYER | Poland | Injection | 115 | VLS | $9.64 | $1K | AHMEDABAD AIR | WARSAW | AIR |
| 76 | Nov 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 3.8K | VLS | $6.33 | $24K | AHMEDABAD AIR | ATHENS | AIR |
| 77 | Nov 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 119 | VLS | $6.33 | $752.96 | AHMEDABAD AIR | ATHENS | AIR |
| 78 | Nov 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 1.5K | VLS | $9.92 | $15K | AHMEDABAD AIR | ATHENS | AIR |
| 79 | Nov 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 115 | VLS | $9.92 | $1K | AHMEDABAD AIR | ATHENS | AIR |
| 80 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 7.2K | VLS | $6.42 | $46K | MUNDRA SEA | Gdynia | SEA |
| 81 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 119 | VLS | $6.42 | $764.48 | MUNDRA SEA | Gdynia | SEA |
| 82 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 7.2K | VLS | $6.42 | $46K | MUNDRA SEA | Gdynia | SEA |
| 83 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 119 | VLS | $6.42 | $764.48 | MUNDRA SEA | Gdynia | SEA |
| 84 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 3.3K | VLS | $6.42 | $21K | MUNDRA SEA | Gdynia | SEA |
| 85 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 119 | VLS | $6.42 | $764.48 | MUNDRA SEA | Gdynia | SEA |
| 86 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 3.6K | VLS | $9.72 | $35K | MUNDRA SEA | Gdynia | SEA |
| 87 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 115 | VLS | $9.72 | $1K | MUNDRA SEA | Gdynia | SEA |
| 88 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 1.4K | VLS | $9.72 | $14K | MUNDRA SEA | Gdynia | SEA |
| 89 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 115 | VLS | $9.72 | $1K | MUNDRA SEA | Gdynia | SEA |
| 90 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $8.98 | $323.28 | AHMEDABAD AIR | MALTA | AIR |
| 91 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 38 | VLS | $5.11 | $194.14 | AHMEDABAD AIR | MALTA | AIR |
| 92 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $7.73 | $278.30 | AHMEDABAD AIR | MALTA | AIR |
| 93 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $7.73 | $278.30 | AHMEDABAD AIR | MALTA | AIR |
| 94 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 38 | VLS | $5.32 | $202.20 | AHMEDABAD AIR | MALTA | AIR |
| 95 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $8.33 | $299.98 | AHMEDABAD AIR | MALTA | AIR |
| 96 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 38 | VLS | $5.14 | $195.42 | AHMEDABAD AIR | MALTA | AIR |
| 97 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 51 | VLS | $3.38 | $172.47 | AHMEDABAD AIR | MALTA | AIR |
| 98 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $8.31 | $216.00 | AHMEDABAD AIR | MALTA | AIR |
| 99 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $8.31 | $216.00 | AHMEDABAD AIR | MALTA | AIR |
| 100 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $8.31 | $216.00 | AHMEDABAD AIR | MALTA | AIR |
| 101 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 51 | VLS | $3.43 | $174.99 | AHMEDABAD AIR | MALTA | AIR |
| 102 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 51 | VLS | $3.41 | $173.96 | AHMEDABAD AIR | MALTA | AIR |
| 103 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 51 | VLS | $3.37 | $171.89 | AHMEDABAD AIR | MALTA | AIR |
| 104 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 51 | VLS | $3.46 | $176.54 | AHMEDABAD AIR | MALTA | AIR |
| 105 | Nov 2025 | BROCACEF NL:EU HUB | Netherlands | 512 | VLS | $4.36 | $2K | AHMEDABAD AIR | AMSTERDAM, SCHIPHOL | AIR | |
| 106 | Nov 2025 | BROCACEF NL:EU HUB | Netherlands | 145 | TBS | $4.36 | $632.90 | AHMEDABAD AIR | AMSTERDAM, SCHIPHOL | AIR | |
| 107 | Nov 2025 | UNKNOWN BUYER | Netherlands | Injection | 2.9K | VLS | $11.01 | $32K | MUNDRA SEA | Rotterdam | SEA |
| 108 | Nov 2025 | UNKNOWN BUYER | Netherlands | Injection | 95 | VLS | $11.01 | $1K | MUNDRA SEA | Rotterdam | SEA |
| 109 | Nov 2025 | UNKNOWN BUYER | Netherlands | Injection | 347 | VLS | $10.84 | $4K | MUNDRA SEA | Rotterdam | SEA |
| 110 | Nov 2025 | UNKNOWN BUYER | Netherlands | Injection | 115 | VLS | $10.84 | $1K | MUNDRA SEA | Rotterdam | SEA |
| 111 | Nov 2025 | UNKNOWN BUYER | Netherlands | 512 | VLS | $4.36 | $2K | AHMEDABAD AIR | AMSTERDAM, SCHIPHOL | AIR | |
| 112 | Nov 2025 | UNKNOWN BUYER | Netherlands | 145 | TBS | $4.36 | $632.90 | AHMEDABAD AIR | AMSTERDAM, SCHIPHOL | AIR | |
| 113 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 7.2K | VLS | $6.55 | $47K | MUNDRA SEA | Gdynia | SEA |
| 114 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 119 | VLS | $6.55 | $780.01 | MUNDRA SEA | Gdynia | SEA |
| 115 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 10.7K | VLS | $4.79 | $51K | MUNDRA SEA | Gdynia | SEA |
| 116 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 145 | VLS | $4.79 | $694.15 | MUNDRA SEA | Gdynia | SEA |
| 117 | Nov 2025 | UNKNOWN BUYER | Poland | Injection | 7.2K | VLS | $6.55 | $47K | MUNDRA SEA | Gdynia | SEA |
| 118 | Nov 2025 | UNKNOWN BUYER | Poland | Injection | 119 | VLS | $6.55 | $780.01 | MUNDRA SEA | Gdynia | SEA |
| 119 | Nov 2025 | UNKNOWN BUYER | Poland | Injection | 10.7K | VLS | $4.79 | $51K | MUNDRA SEA | Gdynia | SEA |
| 120 | Nov 2025 | UNKNOWN BUYER | Poland | Injection | 145 | VLS | $4.79 | $694.15 | MUNDRA SEA | Gdynia | SEA |
| 121 | Nov 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.848 | $21.19 | AHMEDABAD AIR | ATHENS | AIR |
| 122 | Nov 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.848 | $21.19 | AHMEDABAD AIR | ATHENS | AIR |
| 123 | Nov 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.911 | $22.78 | AHMEDABAD AIR | ATHENS | AIR |
| 124 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 26 | VLS | $8.42 | $218.84 | AHMEDABAD AIR | MALTA | AIR |
| 125 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 3.7K | VLS | $4.49 | $17K | MUNDRA SEA | Piraeus | SEA |
| 126 | Nov 2025 | UNLISTED BUYER | Greece | Injection | 145 | VLS | $4.49 | $651.36 | MUNDRA SEA | Piraeus | SEA |
| 127 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 3.6K | VLS | $9.90 | $36K | MUNDRA SEA | Gdynia | SEA |
| 128 | Nov 2025 | UNLISTED BUYER | Poland | Injection | 115 | VLS | $9.90 | $1K | MUNDRA SEA | Gdynia | SEA |
| 129 | Nov 2025 | BROCACEF NL : EU HUB | Netherlands | 1.4K | VLS | $19.55 | $27K | MUNDRA SEA | Rotterdam | SEA | |
| 130 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $8.43 | $303.66 | AHMEDABAD AIR | MALTA | AIR |
| 131 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 21 | VLS | $17.83 | $374.46 | AHMEDABAD AIR | MALTA | AIR |
| 132 | Nov 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $9.80 | $352.73 | AHMEDABAD AIR | MALTA | AIR |
| 133 | Dec 2025 | BROCACEF NL:EU HUB | Netherlands | Injection | 3.6K | VLS | $10.94 | $39K | MUNDRA SEA | Rotterdam | SEA |
| 134 | Dec 2025 | BROCACEF NL:EU HUB | Netherlands | Injection | 115 | VLS | $10.94 | $1K | MUNDRA SEA | Rotterdam | SEA |
| 135 | Dec 2025 | BROCACEF NL : LOCAL | Netherlands | Injection | 6.0K | VLS | $6.98 | $42K | MUNDRA SEA | Rotterdam | SEA |
| 136 | Dec 2025 | BROCACEF NL : LOCAL | Netherlands | Injection | 115 | VLS | $6.98 | $802.17 | MUNDRA SEA | Rotterdam | SEA |
| 137 | Dec 2025 | UNLISTED BUYER | Malta | Injection | 36 | VLS | $5.67 | $204.23 | AHMEDABAD AIR | MALTA | AIR |
| 138 | Dec 2025 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | Injection | 25 | NOS | $0.919 | $22.97 | AHMEDABAD AIR | ATHENS | AIR |
| 139 | Dec 2025 | UNLISTED BUYER | Poland | Injection | 3.6K | VLS | $9.95 | $35K | MUNDRA SEA | Gdynia | SEA |
| 140 | Dec 2025 | UNLISTED BUYER | Poland | Injection | 115 | VLS | $9.95 | $1K | MUNDRA SEA | Gdynia | SEA |
| SUPPLIER #2 — MYLAN LABORATORIES LTD · 1 shipments · $140K | |||||||||||
| 141 | Oct 2025 | CSP P/O VIATRIS SA | France | Injection | 1.9K | NOS | $75.13 | $140K | BANGALORE AIR | PARIS | AIR |
| SUPPLIER #3 — RUS MED EXPORTS PVT LTD · 1 shipments · $94K | |||||||||||
| 142 | Oct 2025 | LLC MANAS MED | Russia | Injection | 19.1K | VLS | $4.90 | $94K | HYDERABAD AIR | MOSCOW DOMODEDOVO | AIR |
| SUPPLIER #4 — FRESENIUS KABI ONCOLOGY LTD · 3 shipments · $69K | |||||||||||
| 143 | Oct 2025 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | Injection | 14.8K | NOS | $4.56 | $68K | DADRI ICD | HAMBURG | ICD |
| 144 | Nov 2025 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | Injection | 62 | VLS | $9.06 | $561.48 | DELHI AIR | BUDAPEST, | AIR |
| 145 | Nov 2025 | UNKNOWN BUYER | Hungary | Injection | 62 | VLS | $9.06 | $561.48 | DELHI AIR | BUDAPEST, | AIR |
| SUPPLIER #5 — UNITED BIOTECH PVT LTD · 2 shipments · $21K | |||||||||||
| 146 | Nov 2025 | UNLISTED BUYER | Lithuania | Injection | 16.3K | NOS | $1.26 | $21K | DELHI AIR | VILNIUS | AIR |
| 147 | Dec 2025 | UNLISTED BUYER | Russia | Injection | 500 | NOS | $1.40 | $700.46 | DELHI AIR | MOSCOW | AIR |
| SUPPLIER #6 — BRUCK PHARMA PVT LTD · 1 shipments · $2K | |||||||||||
| 148 | Dec 2025 | UNLISTED BUYER | Bosnia and Herzegovina | Capsule | 250 | NOS | $9.37 | $2K | MUMBAI AIR (SAHAR) | SARAJEVO | AIR |
| SUPPLIER #7 — GENETEC LIFESCIENCES · 1 shipments · $2K | |||||||||||
| 149 | Dec 2025 | AURORA LLC | Russia | Injection | 1.0K | NOS | $1.99 | $2K | MUMBAI AIR (SAHAR) | MOSCOW | AIR |
| SUPPLIER #8 — VAMA LIFECARE PVT LTD · 1 shipments · $397.75 | |||||||||||
| 150 | Dec 2025 | AS PER INVOICE POLAND | Poland | Capsule | 100 | NOS | $3.98 | $397.75 | MUMBAI AIR (SAHAR) | WARSAW | AIR |
| SUPPLIER #9 — SPECIALITY MEDICINES LTD · 1 shipments · $28.00 | |||||||||||
| 151 | Dec 2025 | UNLISTED BUYER | Lithuania | Injection | 20 | SET | $1.40 | $28.00 | MUMBAI AIR (SAHAR) | VILNIUS | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
10 countries · 19 shipments · $182K · 11 Indian suppliers · 11 buyers
SHIPMENTS
19
USD
$182K
COUNTRIES
10
SUPPLIERS
11
BUYERS
11
HHI
7,041
concentrated
Top 10 destination countries in Americas
1
United States (43.6%)
$79K
2
Mexico (41.2%)
$75K
3
Chile (11.3%)
$21K
4
Costa Rica (3.8%)
$7K
5
Haiti (0.1%)
$186.58
6
Colombia (0.1%)
$96.71
7
Venezuela (0.0%)
$40.68
8
Jamaica (0.0%)
$12.75
9
Cayman Islands (0.0%)
$0.837
10
Trinidad and Tobago (0.0%)
$0.499
Top 11 Indian suppliers into Americas
1
INTAS PHARMACEUTICALS LTD
$151K
2
ADMAC LIFESCIENCES
$21K
3
VENUS REMEDIES LTD
$7K
4
MYGENIC HEALTHCARE PVT LTD
$3K
5
DOSSMEGT PHARMACEUTICALS PVT LTD
$186.58
6
ATLAS ENTERPRISES
$156.66
7
MEDINEX HEALTHCARE
$76.49
8
AMRS HEALTHCARE PVT LTD
$40.68
9
DISTINCT IMPEX PVT LTD
$12.75
10
NARAYANA HRUDAYALAYA LTD
$0.837
11
GETWELL PHARMA INDIA PVT LTD
$0.499
Top 10 Americas importers
1
AMERISOURCE HEALTH SERVICES · United States
$79K
2
ACCORD FARMA S.A. DE C.V · Mexico
$72K
3
SPECIALTY LAB SPA · Chile
$21K
4
P D T S A · Costa Rica
$7K
5
HOPITAL CARAMED CLINIQUE DU CANCE · Haiti
$186.58
6
DISTRIBUIDORA MEDICA PAREDES S.DE · Mexico
$149.83
7
A.SAS · Colombia
$96.71
8
DISTRIBUIDORA MEDICA PAREDES S.DE R · Mexico
$6.83
9
HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands
$0.837
10
SUNCREST INTERNATIONAL LTD · Trinidad and Tobago
$0.499
Top 5 dosage forms
1
Injection
$110K
2
Vaccine
$72K
3
Unknown
$149.83
4
Vial
$76.49
5
Capsule
$40.68
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $151K | $50K |
| Nov | 5 | $7K | $1K |
| Dec | 11 | $24K | $2K |
Shipment register · 19 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INTAS PHARMACEUTICALS LTD · 3 shipments · $151K | |||||||||||
| 1 | Oct 2025 | ACCORD FARMA S.A. DE C.V | Mexico | Vaccine | 10.8K | VLS | $2.41 | $26K | AHMEDABAD AIR | MEXICO CITY | AIR |
| 2 | Oct 2025 | ACCORD FARMA S.A. DE C.V | Mexico | Vaccine | 10.9K | VLS | $4.22 | $46K | AHMEDABAD AIR | MEXICO CITY | AIR |
| 3 | Oct 2025 | AMERISOURCE HEALTH SERVICES | United States | Injection | 1.9K | VLS | $40.91 | $79K | AHMEDABAD AIR | CHICAGO, IL | AIR |
| SUPPLIER #2 — ADMAC LIFESCIENCES · 1 shipments · $21K | |||||||||||
| 4 | Dec 2025 | SPECIALTY LAB SPA | Chile | Injection | 5.1K | NOS | $4.03 | $21K | DELHI AIR | SANTIAGO DE CHILE - | AIR |
| SUPPLIER #3 — VENUS REMEDIES LTD · 2 shipments · $7K | |||||||||||
| 5 | Nov 2025 | P D T S A | Costa Rica | Injection | 4.5K | NOS | $1.52 | $7K | DELHI AIR | SAN JOSE | AIR |
| 6 | Dec 2025 | A.SAS | Colombia | Injection | 8.0K | NOS | $0.012 | $96.71 | DELHI AIR | BOGOTA | SEA |
| SUPPLIER #4 — MYGENIC HEALTHCARE PVT LTD · 3 shipments · $3K | |||||||||||
| 7 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 500 | NOS | $1.93 | $964.78 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 8 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 500 | NOS | $1.93 | $964.78 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 9 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 500 | NOS | $1.93 | $963.83 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #5 — DOSSMEGT PHARMACEUTICALS PVT LTD · 1 shipments · $186.58 | |||||||||||
| 10 | Nov 2025 | HOPITAL CARAMED CLINIQUE DU CANCE | Haiti | Injection | 100 | NOS | $1.87 | $186.58 | MUMBAI AIR (SAHAR) | PORT AU PRINCE | AIR |
| SUPPLIER #6 — ATLAS ENTERPRISES · 3 shipments · $156.66 | |||||||||||
| 11 | Nov 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE | Mexico | 20 | NOS | $1.50 | $29.97 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR | |
| 12 | Nov 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE | Mexico | 80 | NOS | $1.50 | $119.86 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR | |
| 13 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Injection | 400 | NOS | $0.017 | $6.83 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #7 — MEDINEX HEALTHCARE · 2 shipments · $76.49 | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Mexico | Vial | 30 | VLS | $1.53 | $45.89 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Mexico | Vial | 20 | VLS | $1.53 | $30.59 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #8 — AMRS HEALTHCARE PVT LTD · 1 shipments · $40.68 | |||||||||||
| 16 | Dec 2025 | UNLISTED BUYER | Venezuela | Capsule | 6.1K | NOS | $0.0066 | $40.68 | DELHI AIR | CARACAS | AIR |
| SUPPLIER #9 — DISTINCT IMPEX PVT LTD · 1 shipments · $12.75 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Jamaica | Injection | 10 | NOS | $1.27 | $12.75 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| SUPPLIER #10 — NARAYANA HRUDAYALAYA LTD · 1 shipments · $0.837 | |||||||||||
| 18 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Injection | 21 | NOS | $0.040 | $0.837 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #11 — GETWELL PHARMA INDIA PVT LTD · 1 shipments · $0.499 | |||||||||||
| 19 | Nov 2025 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | Injection | 2 | NOS | $0.250 | $0.499 | DELHI AIR | PORT OF SPAIN, PIARC | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $0.0000 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$0.0000
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
NaN
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea · Papua New Guinea
$0.0000
Top 1 Indian suppliers into Oceania
1
ARIHANT EXPORTERS
$0.0000
Top 1 Oceania importers
1
SESAGO HEALTHCARE LTD · Papua New Guinea
$0.0000
Top 1 dosage forms
1
Injection
$0.0000
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $0.0000 | $0.0000 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ARIHANT EXPORTERS · 1 shipments · $0.0000 | |||||||||||
| 1 | Dec 2025 | SESAGO HEALTHCARE LTD | Papua New Guinea | Injection | 150 | PCS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 62 Indian etoposide exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped etoposide in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LTD | AHMEDABAD | 143 | $1.51M | Injection, Vaccine, Solution | Europe, Americas |
| 2 | MYLAN LABORATORIES LTD | BANGALORE | 1 | $140K | Injection | Europe |
| 3 | FRESENIUS KABI ONCOLOGY LTD | NEW DELHI | 7 | $112K | Injection | Europe, Asia |
| 4 | RUS MED EXPORTS PVT LTD | Mumbai | 1 | $94K | Injection | Europe |
| 5 | UNITED BIOTECH PVT LTD | NEW DELHI | 6 | $25K | Injection | Asia, Europe |
| 6 | ADMAC LIFESCIENCES | BADDI | 1 | $21K | Injection | Americas |
| 7 | VENUS REMEDIES LTD | Behra | 4 | $11K | Injection | Americas, Africa |
| 8 | KHANDELWAL LABORATORIES PVT LTD | THANE | 1 | $4K | Capsule | Asia |
| 9 | BRUCK PHARMA PVT LTD | NANI | 2 | $3K | Capsule, Injection | Europe, Africa |
| 10 | MYGENIC HEALTHCARE PVT LTD | NAVI MUMBAI | 3 | $3K | Injection | Americas |
| 11 | BIOZENTA LIFESCIENCE PVT LTD | Una | 2 | $2K | Injection | Asia |
| 12 | NEOPHAR PHARMACEUTICALS PVT LTD | DELHI | 1 | $2K | Injection | Africa |
| 13 | ZUVIUS LIFESCIENCES PVT LTD | GHATKOPAR (E) | 1 | $2K | Injection | Africa |
| 14 | GENETEC LIFESCIENCES | MUMBAI | 1 | $2K | Injection | Europe |
| 15 | PNT PHARMA | MUMBAI | 1 | $2K | Tablet | Africa |
| 16 | J.A. UNITED EXPORTS PVT LTD | VASHI | 4 | $2K | Capsule, Injection | Asia, Africa |
| 17 | GETWELL PHARMA INDIA PVT LTD | GURGAON | 4 | $2K | Injection | Africa, Americas |
| 18 | CHAWLA MEDICOS | NEW DELHI | 1 | $2K | Injection | Africa |
| 19 | BETA DRUGS LTD | BADDI | 1 | $1K | Capsule | Asia |
| 20 | M.K.PHARMA | BHAWANI MANDI | 3 | $1K | Vial | Asia |
| 21 | VANDAN HEALTHCARE | AHMEDABAD | 1 | $1K | Injection | Asia |
| 22 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 5 | $1K | Injection | Africa |
| 23 | MEDEX PHARMACEUTICALS | KULASEKHARAM POST | 4 | $848.00 | Injection | Asia |
| 24 | ZIL PHARMA | MUMBAI | 1 | $817.59 | Injection | Asia |
| 25 | VATS INDUSTRIES PVT LTD | NEW DELHI | 2 | $773.61 | Tablet | Asia |
| 26 | ZEAL PHARMA | NEW KOSAD ROAD AMROLI | 5 | $656.59 | Capsule | Asia |
| 27 | GALAXY SUPER SPECIALITY | NEW DELHI | 1 | $636.82 | Injection | Asia |
| 28 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 3 | $614.67 | Capsule, Injection | Asia |
| 29 | JMB PHARMACEUTICALS PVT LTD | MUMBAI | 3 | $465.43 | Injection | Asia |
| 30 | RMPL PHARMA LLP | MUMBAI | 2 | $433.05 | Injection | Africa, Asia |
| 31 | MATHI ASSOCIATES | MUMBAI | 3 | $412.13 | Injection, Tablet | Africa |
| 32 | VAMA LIFECARE PVT LTD | MUMBAI | 1 | $397.75 | Capsule | Europe |
| 33 | TRIKAYA GLOBAL | MUMBAI | 2 | $331.61 | Capsule | Asia |
| 34 | DROPS PHARMA PVT LTD | HOSDURG | 3 | $312.22 | Injection | Asia |
| 35 | MUNANI PHARMACEUTICALS PVT LTD | MUMBAI | 1 | $278.36 | Capsule | Asia |
| 36 | RUN MEDWAY | SURAT | 1 | $254.98 | Injection | Africa |
| 37 | BARAKAH BIOHEALTH LLP | TIRUPPUR | 1 | $237.81 | Injection | Africa |
| 38 | SUBHRA PHARMA PRIAVATE LTD | Navghar Mulund East Mumbai | 2 | $222.53 | Capsule | Africa |
| 39 | DOSSMEGT PHARMACEUTICALS PVT LTD | MULUND WEST | 1 | $186.58 | Injection | Americas |
| 40 | PHARMA CHOICE LLP | MULUND EAST | 1 | $184.98 | Injection | Asia |
| 41 | SAYAR LIFE-CARE | Chennai | 1 | $165.68 | Vial | Africa |
| 42 | KLV HEALTHCARE PVT LTD | DAHISAR | 1 | $163.28 | Vial | Africa |
| 43 | ATLAS ENTERPRISES | NAGPUR | 3 | $156.66 | Injection | Americas |
| 44 | KHATU ENTERPRISES | NAGPUR | 1 | $134.40 | Injection | Africa |
| 45 | SAMEEKSHA PHARMACEUTICALS PVT LTD | PUNE | 1 | $107.91 | Injection | Africa |
| 46 | SOINS IMPEX | PHASE-1 | 1 | $103.30 | Capsule | Africa |
| 47 | ZYPHARS PHARMACEUTICS PVT LTD | PUNE | 2 | $92.72 | Capsule | Asia, Africa |
| 48 | MEDINEX HEALTHCARE | Mumbai | 2 | $76.49 | Vial | Americas |
| 49 | MC PHARMA DISTRIBUTORS | CHENNAI | 1 | $70.29 | Capsule | Asia |
| 50 | DM WORLDWIDE TRADING | MAHESANA | 1 | $45.38 | Injection | Africa |
| 51 | AL-ROYAL PHARMACEUTICAL PVT LTD | NEW DELHI | 1 | $44.87 | Capsule | Africa |
| 52 | AMRS HEALTHCARE PVT LTD | NOIDA | 1 | $40.68 | Capsule | Americas |
| 53 | MELON GLOBALCARE | MUMBAI | 1 | $29.02 | Injection | Africa |
| 54 | SPECIALITY MEDICINES LTD | MUMBAI | 1 | $28.00 | Injection | Europe |
| 55 | VAMA HEALTH WORLD LLP | Mumbai | 2 | $27.59 | Injection, Capsule | Africa |
| 56 | DISTINCT IMPEX PVT LTD | MUMBAI | 1 | $12.75 | Injection | Americas |
| 57 | M T MADON EXPORTS | MUMBAI | 1 | $9.00 | Injection | Africa |
| 58 | SANSKRUTI PHARMA | SURAT | 1 | $4.29 | Injection | Africa |
| 59 | RUTVA MEDICARE | SURAT | 1 | $1.14 | Africa | |
| 60 | NARAYANA HRUDAYALAYA LTD | BANGALORE | 1 | $0.837 | Injection | Americas |
| 61 | SR FARMALIFE PVT LTD | MUMBAI | 1 | $0.224 | Injection | Africa |
| 62 | ARIHANT EXPORTERS | SURENDRANAGAR | 1 | $0.0000 | Injection | Oceania |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 55 global etoposide importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian etoposide in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | CSP P/O VIATRIS SA | France | 1 | $140K | MYLAN LABORATORIES LTD | Injection |
| 2 | LLC MANAS MED | Russia | 1 | $94K | RUS MED EXPORTS PVT … | Injection |
| 3 | ACCORD HEALTHCARE FRANCE SAS | Netherlands | 6 | $84K | INTAS PHARMACEUTICAL… | Injection |
| 4 | AMERISOURCE HEALTH SERVICES | United States | 1 | $79K | INTAS PHARMACEUTICAL… | Injection |
| 5 | ACCORD FARMA S.A. DE C.V | Mexico | 2 | $72K | INTAS PHARMACEUTICAL… | Vaccine |
| 6 | FRESENIUS KABI DEUTSCHLAND GMBH | Germany | 1 | $68K | FRESENIUS KABI ONCOL… | Injection |
| 7 | BROCACEF NL:EU HUB | Netherlands | 4 | $44K | INTAS PHARMACEUTICAL… | Injection |
| 8 | BROCACEF NL : LOCAL | Netherlands | 2 | $43K | INTAS PHARMACEUTICAL… | Injection |
| 9 | ACCORD HEALTHCARE SINGLE MEMBER SA | Greece | 21 | $41K | INTAS PHARMACEUTICAL… | Injection |
| 10 | FRESENIUS KABI SOUTH AFRICA (PTY) L | South Africa | 2 | $35K | FRESENIUS KABI ONCOL… | Injection |
| 11 | BROCACEF NL : EU HUB | Netherlands | 1 | $27K | INTAS PHARMACEUTICAL… | |
| 12 | SPECIALTY LAB SPA | Chile | 1 | $21K | ADMAC LIFESCIENCES | Injection |
| 13 | ACCORD HEALTHCARE ITALIA SRL | Italy | 2 | $16K | INTAS PHARMACEUTICAL… | Injection |
| 14 | P D T S A | Costa Rica | 1 | $7K | VENUS REMEDIES LTD | Injection |
| 15 | MEGA SUNSHINE COMPANY LTD | Myanmar | 1 | $4K | KHANDELWAL LABORATOR… | Capsule |
| 16 | ATCO PHARMA INTERNATIONAL PVT LTD | Pakistan | 1 | $4K | FRESENIUS KABI ONCOL… | Injection |
| 17 | R M S | Rwanda | 1 | $4K | VENUS REMEDIES LTD | Injection |
| 18 | SAK CAM PHARMA CO LTD | Cambodia | 1 | $3K | UNITED BIOTECH PVT LTD | Injection |
| 19 | CENTRALE D ACHATS DE MEDICAMENTS | Madagascar | 1 | $2K | ZUVIUS LIFESCIENCES … | Injection |
| 20 | AURORA LLC | Russia | 1 | $2K | GENETEC LIFESCIENCES | Injection |
| 21 | TO THE | Rwanda | 1 | $2K | PNT PHARMA | Tablet |
| 22 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 4 | $2K | J.A. UNITED EXPORTS … | Capsule, Injection |
| 23 | SIJAL PHARMA PVT LTD | Nepal | 1 | $1K | BETA DRUGS LTD | Capsule |
| 24 | LLC TIBBI JAHON | Tajikistan | 3 | $1K | M.K.PHARMA | Vial |
| 25 | VISION CARE INTERNATIONAL PVT LTD | Nepal | 1 | $1K | GETWELL PHARMA INDIA… | Injection |
| 26 | BEST INTERNATIONAL FZE | United Arab Emirates | 4 | $848.00 | MEDEX PHARMACEUTICALS | Injection |
| 27 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 3 | $614.67 | SEATRACK INTERNATION… | Capsule, Injection |
| 28 | EUROFINS BIOPHARMA PRODUCT TESTING | Hungary | 1 | $561.48 | FRESENIUS KABI ONCOL… | Injection |
| 29 | THE ESSES PHARMACY (PRIVATE) | Sri Lanka | 1 | $481.09 | GETWELL PHARMA INDIA… | Injection |
| 30 | NIKHIL PHARMA PVT LTD | Nepal | 2 | $477.96 | UNITED BIOTECH PVT LTD | Injection |
| 31 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | 1 | $465.43 | JMB PHARMACEUTICALS … | Injection |
| 32 | PHARMACHEIME LTD | Malawi | 3 | $412.13 | MATHI ASSOCIATES | Injection, Tablet |
| 33 | AS PER INVOICE POLAND | Poland | 1 | $397.75 | VAMA LIFECARE PVT LTD | Capsule |
| 34 | ATLAS TRADING COMPANY | Iraq | 1 | $386.80 | VATS INDUSTRIES PVT … | |
| 35 | CLYZ PHARMA SARL | Cameroon | 1 | $254.98 | RUN MEDWAY | Injection |
| 36 | HOPITAL CARAMED CLINIQUE DU CANCE | Haiti | 1 | $186.58 | DOSSMEGT PHARMACEUTI… | Injection |
| 37 | RADEEP SERVICES | Singapore | 1 | $184.98 | PHARMA CHOICE LLP | Injection |
| 38 | R P L | South Africa | 1 | $167.89 | VENUS REMEDIES LTD | Injection |
| 39 | AUTOMOBILE TRANSPORTATION SERVICES | Lebanon | 1 | $165.80 | TRIKAYA GLOBAL | Capsule |
| 40 | MINISTRY OF HEALTH ( CLAUDE JULIEN | Seychelles | 1 | $165.68 | SAYAR LIFE-CARE | Vial |
| 41 | ACCORD HEALTHCARE SM SA | Greece | 3 | $157.99 | INTAS PHARMACEUTICAL… | Injection |
| 42 | DISTRIBUIDORA MEDICA PAREDES S.DE | Mexico | 2 | $149.83 | ATLAS ENTERPRISES | |
| 43 | OUMAR KONE | Mali | 1 | $134.40 | KHATU ENTERPRISES | Injection |
| 44 | PH.EBENA | Cote d'Ivoire | 1 | $107.91 | SAMEEKSHA PHARMACEUT… | Injection |
| 45 | A.SAS | Colombia | 1 | $96.71 | VENUS REMEDIES LTD | Injection |
| 46 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $70.29 | MC PHARMA DISTRIBUTORS | Capsule |
| 47 | MEDIMART DRUG STORE | United Arab Emirates | 1 | $54.85 | DROPS PHARMA PVT LTD | Injection |
| 48 | ROYAL PHARMA COMPANY | Egypt | 1 | $44.87 | AL-ROYAL PHARMACEUTI… | Capsule |
| 49 | AS PER INVOICE GHANA | Ghana | 2 | $27.59 | VAMA HEALTH WORLD LLP | Injection, Capsule |
| 50 | MOHAMED AHEMED MOHAMUD | Somalia | 1 | $9.00 | M T MADON EXPORTS | Injection |
| 51 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | 1 | $6.83 | ATLAS ENTERPRISES | Injection |
| 52 | HANITRA RAZAOARIMANANA | Madagascar | 1 | $0.865 | GETWELL PHARMA INDIA… | Injection |
| 53 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | 1 | $0.837 | NARAYANA HRUDAYALAYA… | Injection |
| 54 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | 1 | $0.499 | GETWELL PHARMA INDIA… | Injection |
| 55 | SESAGO HEALTHCARE LTD | Papua New Guinea | 1 | $0.0000 | ARIHANT EXPORTERS | Injection |
This report covers 258 2025-Q4 Etoposide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/etoposide
Talk to our trade analyst
Need a custom etoposide report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/etoposide
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Etoposide product page
Live data, supplier directory, price trends, and trade route analysis